Eric K Rowinsky - Net Worth and Insider Trading

Eric K Rowinsky Net Worth

The estimated net worth of Eric K Rowinsky is at least $6 Million dollars as of 2026-08-11. Eric K Rowinsky is the Director of Biogen Inc and owns about 20,629 shares of Biogen Inc (BIIB) stock worth over $4 Million. Eric K Rowinsky is the Chief Medical Officer of Stemline Therapeutics Inc and owns about 143,688 shares of Stemline Therapeutics Inc (STML) stock worth over $2 Million. Eric K Rowinsky is also the Director of Fortress Biotech Inc and owns about 48,000 shares of Fortress Biotech Inc (FBIO) stock worth over $132,000. Besides these, Eric K Rowinsky also holds Verastem Inc (VSTM) , Navidea Biopharmaceuticals Inc (NAVBQ) . Details can be seen in Eric K Rowinsky's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eric K Rowinsky has not made any transactions after 2024-02-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Eric K Rowinsky

To

Eric K Rowinsky Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eric K Rowinsky owns 7 companies in total, including Verastem Inc (VSTM) , Biogen Inc (BIIB) , and Fortress Biotech Inc (FBIO) among others .

Click here to see the complete history of Eric K Rowinsky’s form 4 insider trades.

Insider Ownership Summary of Eric K Rowinsky

Ticker Company Transaction Date Type of Owner
VSTM Verastem Inc 2018-12-31 director
BIIB Biogen Inc 2024-02-15 director
FBIO Fortress Biotech Inc 2021-03-02 director
LIMIT LIMIT 2014-11-10 director
LIMIT LIMIT 2016-08-29 director
LIMIT LIMIT 2015-04-27 Chief Medical Officer
LIMIT LIMIT 2010-02-02 director

Eric K Rowinsky Latest Holdings Summary

Eric K Rowinsky currently owns a total of 5 stocks. Among these stocks, Eric K Rowinsky owns 20,629 shares of Biogen Inc (BIIB) as of February 15, 2024, with a value of $4 Million and a weighting of 69.98%. Eric K Rowinsky owns 143,688 shares of Stemline Therapeutics Inc (STML) as of April 27, 2015, with a value of $2 Million and a weighting of 27.84%. Eric K Rowinsky also owns 48,000 shares of Fortress Biotech Inc (FBIO) as of March 2, 2021, with a value of $132,000 and a weighting of 2.16%. The other 2 stocks Verastem Inc (VSTM) , Navidea Biopharmaceuticals Inc (NAVBQ) have a combined weighting of 0.02% among all his current holdings.

Latest Holdings of Eric K Rowinsky

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BIIB Biogen Inc 2024-02-15 20,629 207.13 4,272,885
STML Stemline Therapeutics Inc 2015-04-27 143,688 11.83 1,699,829
FBIO Fortress Biotech Inc 2021-03-02 48,000 2.75 132,000
VSTM Verastem Inc 2017-09-05 167 6.81 1,137
NAVBQ Navidea Biopharmaceuticals Inc 2011-08-19 750 0.00 0

Holding Weightings of Eric K Rowinsky


Eric K Rowinsky Form 4 Trading Tracker

According to the SEC Form 4 filings, Eric K Rowinsky has made a total of 1 transactions in Biogen Inc (BIIB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Biogen Inc is the acquisition of 455 shares on February 15, 2024, which cost Eric K Rowinsky around $101,256.

According to the SEC Form 4 filings, Eric K Rowinsky has made a total of 0 transactions in Stemline Therapeutics Inc (STML) over the past 5 years. The most-recent trade in Stemline Therapeutics Inc is the sale of 10,824 shares on April 27, 2015, which brought Eric K Rowinsky around $170,694.

According to the SEC Form 4 filings, Eric K Rowinsky has made a total of 0 transactions in Fortress Biotech Inc (FBIO) over the past 5 years. The most-recent trade in Fortress Biotech Inc is the sale of 2,000 shares on March 2, 2021, which brought Eric K Rowinsky around $127,200.

More details on Eric K Rowinsky's insider transactions can be found in the Insider Trading History of Eric K Rowinsky table.

Insider Trading History of Eric K Rowinsky

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Eric K Rowinsky Trading Performance

GuruFocus tracks the stock performance after each of Eric K Rowinsky's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eric K Rowinsky is -0.89%. GuruFocus also compares Eric K Rowinsky's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eric K Rowinsky within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Eric K Rowinsky's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Eric K Rowinsky

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 14.89 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 10.64 LIMIT LIMIT LIMIT LIMIT LIMIT

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Eric K Rowinsky owns.
View BIIB Analysis

Eric K Rowinsky Ownership Network

Ownership Network List of Eric K Rowinsky

No Data

Ownership Network Relation of Eric K Rowinsky

Insider Network Chart


Eric K Rowinsky Owned Company Details

What does Verastem Inc do?

Who are the key executives at Verastem Inc?

Eric K Rowinsky is the director of Verastem Inc. Other key executives at Verastem Inc include Chief Operating Officer Dan Paterson , Vice President of Finance Daniel Calkins , and Chief Financial Officer Robert E. Gagnon .

Verastem Inc (VSTM) Insider Trades Summary

Over the past 18 months, Eric K Rowinsky made no insider transaction in Verastem Inc (VSTM). Other recent insider transactions involving Verastem Inc (VSTM) include a net sale of 145,568 shares made by Dan Paterson , a net sale of 24,659 shares made by Daniel Calkins , and a net sale of 2,366 shares made by Brian M Stuglik .

In summary, during the past 3 months, insiders sold 26,262 shares of Verastem Inc (VSTM) in total and bought 0 shares, with a net sale of 26,262 shares. During the past 18 months, 196,858 shares of Verastem Inc (VSTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 196,858 shares.

Verastem Inc (VSTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Verastem Inc Insider Transactions

No Available Data

Eric K Rowinsky Mailing Address

Above is the net worth, insider trading, and ownership report for Eric K Rowinsky. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Eric K Rowinsky's mailing address is: New York Ny 10014.